-

AM Best Affirms Credit Ratings of Scotia Insurance (Cayman) Limited

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a+” (Excellent) of Scotia Insurance (Cayman) Limited (SIC) (Cayman). The outlook of these Credit Ratings (ratings) is stable.

The ratings reflect SIC’s balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, neutral business profile and appropriate enterprise risk management.

The company reported approximately CAD 270.8 million of equity at fiscal year-end 2025, a decrease from approximately CAD 294.5 million for fiscal year-end 2024. The majority of SIC’s business is creditor life, health and disability reinsurance business, for which the premium allocation approach has been utilized under IFRS 17. For the company’s non-creditor business, SIC holds a contractual service margin liability on its profitable reinsurance contracts, which partly contributed to a decline in reported capital on transition to IFRS 17, but is expected to be released into earnings over time. SIC’s business purpose is to reinsure the insurance protection offered to The Bank of Nova Scotia’s customers through its Canadian retail banking network, allowing the bank to undertake and manage insurance risk. SIC reported profit of approximately CAD 361.2 million, compared with about CAD 379.6 million in fiscal year 2024, primarily due to higher income tax expenses.

The stable outlooks reflect SIC’s very strong balance sheet strength assessment supported by consistently strong operating performance. The company’s favorable operating return-on-equity on a longstanding basis provides significant support to the balance sheet and reflects SIC’s appropriate underwriting practices in its core Canadian creditor life reinsurance product.

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2026 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Mitul Patel
Senior Financial Analyst
+1 908 882 1983
mitul.patel@ambest.com

David Marek
Associate Director
+1 908 882 1924
david.marek@ambest.com

Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
christopher.sharkey@ambest.com

Al Slavin
Senior Public Relations Specialist
+1 908 882 2318
al.slavin@ambest.com

AM Best


Release Versions
Hashtags

Contacts

Mitul Patel
Senior Financial Analyst
+1 908 882 1983
mitul.patel@ambest.com

David Marek
Associate Director
+1 908 882 1924
david.marek@ambest.com

Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
christopher.sharkey@ambest.com

Al Slavin
Senior Public Relations Specialist
+1 908 882 2318
al.slavin@ambest.com

Social Media Profiles
More News From AM Best

Best’s Commentary: Health Insurers Evaluating Balance Between Pharmacy Costs and Long-Term Value of GLP-1 Therapies

OLDWICK, N.J.--(BUSINESS WIRE)--As pharmacy cost trends continue to rise and clinical evidence evolves, health insurers face a fundamental question on whether improvements in long-term morbidity and the potential for improved mortality outcomes ultimately justify significant investments in GLP-1 therapies, according to a new AM Best commentary. The Best’s Commentary, “GLP-1 Therapies: Evaluating the Balance Between Pharmacy Costs and Long-Term Value,” states that GLP-1 therapies have become one...

AM Best Downgrades Credit Ratings of A-CAP Group Members; Maintains Under Review With Negative Implications Status

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has downgraded the Financial Strength Rating (FSR) to C+ (Marginal) from B (Fair) and the Long-Term Issuer Credit Rating (Long-Term ICR) to “b-” (Marginal) from “bb+” (Fair) of Atlantic Coast Life Insurance Company (Charleston, SC) and Sentinel Security Life Insurance Company (Salt Lake City, UT). Both companies are collectively referred to as A-CAP Group. Concurrently, AM Best has maintained the under review with negative implications status for these Cre...

AM Best to Deliver Presentation at 2026 ACLI Annual Conference

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best will speak at the American Council of Life Insurers (ACLI) Annual Conference, which will take place Oct. 14-16, 2026, in Orlando, FL. Kenneth Frino, managing director, and Erik Miller, senior director, both of AM Best, will deliver a presentation, titled, “Life and Annuity Segment in Transition,” during which they will focus on operating results across the life/annuity segment, as well as investment strategies, rating activity trends and AM Best’s segment...
Back to Newsroom